| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Mar-07 | | Total Revenue | 5,137,585 | 1,611,819 | 1,611,819 | | Cost of Revenue | 3,067,364 | 768,151 | 768,151 | | | Gross Profit | 2,070,221 | 843,668 | 843,668 | | | Operating Expenses | | Research Development | 317,217 | 103,692 | 103,692 | | Selling General and Administrative | 1,053,485 | 215,538 | 215,538 | | Non Recurring | 401,634 | 96,884 | 96,884 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 297,885 | 427,554 | 427,554 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,337 | 50,234 | 50,234 | | Earnings Before Interest And Taxes | 309,222 | 477,788 | 477,788 | | Interest Expense | 357,045 | 52,276 | 52,276 | | Income Before Tax | (47,823) | 425,512 | 425,512 | | Income Tax Expense | 137,423 | 208,017 | 208,017 | | Minority Interest | 4,031 | (211) | (211) | | | | Net Income From Continuing Ops | (181,215) | 217,284 | 217,284 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (181,215) | 217,284 | 217,284 | | Preferred Stock And Other Adjustments | (139,035) |
-
|
-
| | | Net Income Applicable To Common Shares | ($320,250) | $217,284 | $217,284 |
|
1.48% Nasdaq 
Income Statement
